Clinical trial
A Prospective, Randomized, and Controlled Clinical Study to Evaluate PROKERA® in the Management of Signs and Symptoms Associated With Dry Eye Disease
NCT04015219 is registered in ClinicalTrials.gov with BioTissue Holdings, Inc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Randomized, and Controlled Clinical Study to Evaluate PROKERA® in the Management of Signs and Symptoms Associated With Dry Eye Disease
- Lead sponsor
- BioTissue Holdings, Inc
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- July 18, 2018
- Completion date
- October 5, 2020
- Enrollment
- 3 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.